Position in UTHR
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$192,891
-$33,034 QoQ
Shares Held
356
-6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#707
of 870 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 20261620 INVESTMENT ADVISORS, INC. holds $895,573 across 9 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
24,191 | $384,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
356 | $192,891 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
997 | $168,034 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,577 | $53,428 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
407 | $45,152 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
834 | $21,158 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
550 | $17,270 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
615 | $12,410 |
All Filings in UTHR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $192,891 | 356 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $225,925 | 381 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $187,104 | 384 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $160,557 | 383 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $110,917 | 386 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $119,608 | 388 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $135,137 | 383 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $144,415 | 403 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $122,960 | 386 | Shares | Sole | 2024-07-23 | |
| No filing history on record for this holder in this stock. | ||||||